Pradel, Bernadeth P.
HRN: 21-70-86 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/14/2022
CEFUROXIME 750MG (VIAL)
08/15/2022
08/21/2022
IV
1.5G
On Call To OR Then Q8
Primary LTCS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes